Calmer Co International (CHIA:CCO) - Stock Price, News & Analysis

CCO Stock Overview

Operates as a health and wellness company in Australia, Fiji, the United States, and internationally. More details

CCO fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Negative shareholders equity

Earnings have declined by 5.6% per year over past 5 years

Does not have a meaningful market cap (A$17M)

+ 2 more risks

The Calmer Co International Limited Competitors

Star Combo Pharma

ASX:S66

AU$15.5m

Bioxyne

ASX:BXN

AU$28.7m

Hydration Pharmaceuticals

ASX:HPC

AU$4.6m

BWX

ASX:BWX

AU$40.0m

Price History & Performance

Summary of all time highs, changes and price drops for Calmer Co International
Historical stock prices
Current Share Price	AU$0.008
52 Week High	AU$0.017
52 Week Low	AU$0.0035
Beta	1.51
11 Month Change	-11.11%
3 Month Change	-5.88%
1 Year Change	n/a
33 Year Change	-90.91%
5 Year Change	-92.00%
Change since IPO	-93.33%

Recent updates

Shareholder Returns

	CCO	AU Personal Products	AU Market
7D	0%	-9.9%	1.2%
1Y	n/a	53.6%	19.7%

Return vs Industry: Insufficient data to determine how CCO performed against the Australian Personal Products industry.

Return vs Market: Insufficient data to determine how CCO performed against the Australian Market.

Price Volatility

Is CCO's price volatile compared to industry and market?
CCO volatility
CCO Average Weekly Movement	14.2%
Personal Products Industry Average Movement	5.7%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.5%
10% least volatile stocks in AU Market	3.2%

Stable Share Price: CCO's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: CCO's weekly volatility has decreased from 29% to 14% over the past year, but is still higher than 75% of Australian stocks.

About the Company

Founded	Employees	CEO	Website
2014	n/a	Anthony Noble	www.thecalmerco.com

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, the United States, and internationally. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; cold pressed shots and kava under the Taki Mai brand name; hemp, CBD oils, topical products, and kava tinctures under Danodan brand name; and nutraceuticals. It also markets Leilo kava beverages.

The Calmer Co International Limited Fundamentals Summary

How do Calmer Co International's earnings and revenue compare to its market cap?
CCO fundamental statistics
Market cap	AU$16.51m
Earnings (TTM)	-AU$3.73m
Revenue (TTM)	AU$4.26m

3.9x

P/S Ratio

-4.4x

P/E Ratio

Is CCO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CCO income statement (TTM)
Revenue	AU$4.26m
Cost of Revenue	AU$2.21m
Gross Profit	AU$2.05m
Other Expenses	AU$5.78m
Earnings	-AU$3.73m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0017
Gross Margin	48.08%
Net Profit Margin	-87.42%
Debt/Equity Ratio	-425.4%

How did CCO perform over the long term?

See historical performance and comparison

CCO Stock Overview

Risk Analysis

The Calmer Co International Limited Competitors

ASX:S66

AU$15.5m

ASX:BXN

AU$28.7m

ASX:HPC

AU$4.6m

ASX:BWX

AU$40.0m

Price History & Performance

Recent News & Updates

Less than half of directors are independent

The Calmer Co International Limited, Annual General Meeting, Nov 29, 2024

MD, CEO & Director recently sold AU$59k worth of stock

The Calmer Co International Limited has completed a Follow-on Equity Offering in the amount of AUD 0.625 million.

The Calmer Co International Limited has completed a Follow-on Equity Offering in the amount of AUD 0.515 million.

The Calmer Co International Limited has completed a Follow-on Equity Offering in the amount of AUD 1 million.

Recent updates

Less than half of directors are independent

The Calmer Co International Limited, Annual General Meeting, Nov 29, 2024

MD, CEO & Director recently sold AU$59k worth of stock

The Calmer Co International Limited has completed a Follow-on Equity Offering in the amount of AUD 0.625 million.

The Calmer Co International Limited has completed a Follow-on Equity Offering in the amount of AUD 0.515 million.

The Calmer Co International Limited has completed a Follow-on Equity Offering in the amount of AUD 1 million.

High number of new and inexperienced directors

First half 2023 earnings released: AU$0.01 loss per share (vs AU$0.017 loss in 1H 2022)

Fiji Kava Limited Announces Executive Changes

Fiji Kava Limited Announces Retirement of Nicholas Simms as Director

Less than half of directors are independent

Fiji Kava Limited, Annual General Meeting, Nov 30, 2022

Fiji Kava Limited has completed a Follow-on Equity Offering in the amount of AUD 1.6 million.

High number of new and inexperienced directors

Fiji Kava Limited (ASX:FIJ) entered into a binding agreement to acquire Kula LLC.

Full year 2022 earnings released: AU$0.033 loss per share (vs AU$0.028 loss in FY 2021)

James Dack Joins Board to Support Fiji Kava Limited US Growth

Fiji Kava Limited, Annual General Meeting, Oct 04, 2022

Full year 2022 earnings released: AU$0.032 loss per share (vs AU$0.028 loss in FY 2021)

Fiji Kava Ltd Announces Resignation of Non-Executive Director, Jack Lowenstein

Fiji Kava Limited announced that it expects to receive AUD 0.75 million in funding

High number of new and inexperienced directors

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Fiji Kava Common Stock to Be Deleted from Other OTC

Fiji Kava Limited has completed a Follow-on Equity Offering in the amount of AUD 2.679 million.

Full year 2021 earnings released: AU$0.028 loss per share (vs AU$0.043 loss in FY 2020)

Fiji Kava Limited has completed a Follow-on Equity Offering in the amount of AUD 1.5 million.

Fiji Kava Limited announced that it expects to receive AUD 1.5 million in funding

First half 2021 earnings released: AU$0.014 loss per share (vs AU$0.031 loss in 1H 2020)

Fiji Kava Limited Announces Executive Changes

Full year earnings released - AU$0.043 loss per share

Fiji Kava Limited announced that it has received AUD 4.588518 million in funding

Full year earnings released - AU$0.044 loss per share

Shareholder Returns

Price Volatility

About the Company

The Calmer Co International Limited Fundamentals Summary

3.9x

-4.4x

Earnings & Revenue